Neuropathic pain: emerging treatments

Area of Science:

• Neuroscience
• Pharmacology
• Neurology

Background:

• Neuropathic pain is a complex neurological disorder with significant unmet therapeutic needs.
• Understanding overlapping mechanisms and comorbidities is crucial for developing effective interventions.
• Peripheral and central hyperexcitability are key pathological features.

Purpose of the Study:

• To review current and emerging therapeutic strategies for neuropathic pain.
• To highlight molecular targets and biological approaches for intervention.
• To discuss the potential of novel treatments in clinical validation.

Main Methods:

• Review of molecular drivers of neuropathic pain, including ion channels and ligand-gated channels.
• Exploration of therapeutic targets such as CB1 receptors, glutamate receptors, and neuroglial receptors.
• Discussion of emerging biological therapies including antibodies, siRNA, and gene therapy.

Main Results:

• Ion channel modulation (Nav1.7, Nav1.8, Nav1.3, Cav2.2, alpha2-delta) shows therapeutic potential.
• Blocking ligand-gated channels (TRPV1, TRPM8, NNRs) may alleviate neural sensitization.
• Modulating excitability via CB1 receptors, glutamate receptors, and neuroglial targets offers promising clinical avenues.

Conclusions:

• Targeting ion channels, receptors, and neuroglial pathways presents viable therapeutic strategies for neuropathic pain.
• Emerging biological approaches, including antibodies and gene therapy, represent powerful additions to treatment paradigms.
• Continued clinical validation is essential for translating these interventions into effective therapies for neuropathic pain.